Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Essentra plc is a leading global provider of essential components and solutions, specializing in the manufacture and distribution of plastic injection moulded, vinyl dip moulded, fibre, foam, and metal products. Headquartered in the United Kingdom, the company operates through a network spanning 28 countries, with approximately 3,000 employees, 14 manufacturing facilities, 26 distribution centres, and 37 sales and service locations serving around 64,000 customers. Its product portfolio includes protective caps and plugs, access hardware, cable management, plastic fasteners, electronics hardware, security seals, and components for automotive, EV charging, renewable energy, medical devices, construction, agriculture, automation, telecoms, and consumer equipment. Essentra plc produces about 60 million parts weekly and maintains around 2 billion parts in stock, enabling rapid supply of low-cost, critical items integral to customers' manufacturing bills of materials. Originally demerged from Bunzl in 2005 as Filtrona plc and rebranded in 2013, it has streamlined into a pure-play components business by divesting filters and packaging divisions in 2022, focusing on its vision to be the world’s leading responsible, hassle-free supplier of essential industrial components across diverse end-markets.
£0.85
+£0.03 (+3.29%)
EOD Jul 3, 2026
Operating margin is thin at 6.46%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 0.1% YoY. Margins deteriorated 2.9pp alongside, both lines moving the wrong way.
At 121x earnings, the current multiple leaves limited room for execution misses or growth deceleration. ROIC dropped from 7.04% to 4.87%, capital efficiency is deteriorating.
121.1x earnings, 16.8x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£302M
▼ -0.1% YoY
Net Income (TTM)
£2M
▼ -80.2% YoY
Op. Margin
6.46%
▼ -2.9pp YoY
ROIC
4.87%
▼ -2.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
£14M
▲ +11.6% YoY
Op. Cash Flow (TTM)
£15M
▼ -56.9% YoY
Net Debt
£91M
Cash & Equiv.
£36M
3Y CAGR: -3.7%
3Y CAGR: -14.8%
Continue Research
At a P/E of 121.1 and a price-to-free-cash-flow of 16.8, Essentra (ESNT.XLON) trades above a two-stage DCF intrinsic value of about £0.56 per share, so at £0.85 the stock looks overvalued (34.4% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Essentra scores 41/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 2.8%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about £0.56 per share for ESNT.XLON, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around £0.42. At today's £0.85, that puts the stock about 34.4% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Essentra scores 41 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 6.5% operating margin and a 4.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Essentra pays a regular dividend of about £0.02 per share per year (typically in quarterly installments), a yield of roughly 2.8% at the current price. That is a payout ratio of about 319.0% of earnings, so the dividend is stretched at this level. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For ESNT.XLON's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. ESNT.XLON currently trades above its estimated intrinsic value and scores 41/100 on quality (mixed). It also yields about 2.8%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.